Studies comparing clinicopathological characteristics with ER protein expression (typically evaluated by immunohistochemistry (IHC)) in tumor tissue show differential relation to disease prognosis based on cellular localization and cancer type. This evidence concerns the gene ESR1 and neoplasm.